These effects, together with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 assist the concept of targeting ACKR3 as a novel strategy to modulate the opioid method, which could open new therapeutic avenues for opioid-linked Diseases. Title your collection: Title should be https://davidb406mcs1.mybuzzblog.com/profile